Indication Competition

Explore the competitive landscape by medical indication. See which companies are developing drugs for specific diseases, their clinical trial stages, and FDA approval timelines.

Search coming soon. Browse by therapeutic area below.

Hot Indications

Cystic Fibrosis

15 Phase 335 total

Non-small Cell Lung Cancer

11 Phase 319 total

Diabetes

10 Phase 311 total

Type 2 Diabetes Mellitus

9 Phase 314 total

SARS-CoV-2 Infection

7 Phase 38 total

Active Indications

371

Total Competitors

162

Phase 3 Programs

Browse by Therapeutic Area

🎗️Oncology

Non-small Cell Lung Cancer19 Breast Cancer11 Ovarian Cancer11 Prostate Cancer9 Multiple Myeloma6 +6 more indications

🧠Neurology & CNS

Schizophrenia9 Alzheimer Disease9 Migraine4

🛡️Immunology & Inflammation

Rheumatoid Arthritis17 Atopic Dermatitis13 Psoriasis5 Plaque Psoriasis5 Chronic Graft-versus-host-disease4 +1 more indications

🦠Infectious Disease

Hepatitis C8 Covid-198 Pneumococcal Vaccines5 Influenza4

🧬Rare & Genetic Diseases

Cystic Fibrosis35 Duchenne Muscular Dystrophy6 Sickle Cell Disease4

⚡Metabolic & Endocrine

Type 2 Diabetes Mellitus14 Diabetes11 Diabetes Mellitus, Type 29 Obesity7 Type 1 Diabetes4

👁️Ophthalmology

Uveitis4

🩹Dermatology

Acne Vulgaris9 Papulopustular Rosacea4

Track Your Favorite Indications

Add companies to your watchlist to get notified when competitors reach key milestones in the same therapeutic areas.

Go to Watchlist